Related Experiment Video
Updated: Nov 28, 2025

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Current understanding of CREPT and p15RS, carboxy-terminal domain (CTD)-interacting proteins, in human cancers
Mengdi Li1, Danhui Ma1, Zhijie Chang2
1State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, 100084, Beijing, China.
Abstract:
CREPT and p15RS, also named RPRD1B and RPRD1A, are RPRD (regulation of nuclear pre-mRNA-domain-containing) proteins containing C-terminal domain (CTD)-interacting domain (CID), which mediates the binding to the CTD of Rpb1, the largest subunit of RNA polymerase II (RNAPII). CREPT and p15RS are highly conserved, with a common yeast orthologue Rtt103. Intriguingly, human CREPT and p15RS possess opposite functions in the regulation of cell proliferation and tumorigenesis. While p15RS inhibits cell proliferation, CREPT promotes cell cycle and tumor growth. Aberrant expression of both CREPT and p15RS was found in numerous types of cancers. At the molecular level, both CREPT and p15RS were reported to regulate gene transcription by interacting with RNAPII. However, CREPT also exerts a key function in the processes linked to DNA damage repairs. In this review, we summarized the recent studies regarding the biological roles of CREPT and p15RS, as well as the molecular mechanisms underlying their activities. Fully revealing the mechanisms of CREPT and p15RS functions will not only provide new insights into understanding gene transcription and maintenance of DNA stability in tumors, but also promote new approach development for tumor diagnosis and therapy.
Insights
Regulation of nuclear pre-mRNA-domain-containing (RPRD) proteins CREPT and p15RS have opposing roles in cell proliferation and cancer. Understanding their functions in transcription and DNA repair could lead to new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- CREPT and p15RS are conserved RPRD proteins that bind the C-terminal domain (CTD) of RNA polymerase II (RNAPII).
- These proteins share a yeast orthologue, Rtt103, but exhibit opposing functions in human cells.
- Aberrant expression of CREPT and p15RS is implicated in various cancers.
Purpose of the Study:
- To review recent studies on the biological roles of CREPT and p15RS.
- To elucidate the molecular mechanisms underlying their functions in gene transcription and DNA repair.
- To explore their potential as targets for cancer diagnosis and therapy.
Main Methods:
- Literature review of recent studies on CREPT and p15RS.
- Analysis of molecular mechanisms involving RNAPII interaction.
- Investigation of roles in DNA damage repair pathways.
Main Results:
- CREPT promotes cell cycle progression and tumor growth, while p15RS inhibits proliferation.
- Both proteins regulate gene transcription through interaction with RNAPII.
- CREPT plays a significant role in DNA damage repair processes.
Conclusions:
- CREPT and p15RS have distinct and opposing functions in cell proliferation and tumorigenesis.
- Their mechanisms of action involve regulating gene transcription and DNA stability.
- Further understanding of CREPT and p15RS functions may yield novel strategies for cancer treatment.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules